- Report
- April 2026
- 146 Pages
Global
From €3609EUR$3,999USD£3,127GBP
- Report
- January 2026
- 550 Pages
Global
From €4512EUR$5,000USD£3,910GBP
- Report
- November 2025
- 200 Pages
Global
From €7174EUR$7,950USD£6,217GBP
- Report
- June 2025
- 400 Pages
Global
From €4466EUR$4,949USD£3,870GBP
- Report
- January 2026
- 297 Pages
Global
From €2256EUR$2,500USD£1,955GBP
- Report
- June 2025
- 400 Pages
Global
From €4466EUR$4,949USD£3,870GBP
- Report
- June 2025
- 400 Pages
Global
From €4466EUR$4,949USD£3,870GBP
- Report
- June 2025
- 400 Pages
Global
From €4466EUR$4,949USD£3,870GBP
- Report
- April 2026
- 160 Pages
Global
From €3745EUR$4,150USD£3,245GBP
- Report
- October 2025
- 142 Pages
Global
From €3564EUR$3,950USD£3,089GBP
- Report
- August 2025
- 144 Pages
Global
From €3564EUR$3,950USD£3,089GBP
- Report
- July 2025
- 163 Pages
Global
From €13535EUR$14,999USD£11,729GBP
- Report
- April 2026
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 212 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- November 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- November 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- November 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- November 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- November 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more